Skip to main content
Erschienen in: Pediatric Nephrology 6/2012

01.06.2012 | Brief Report

Maternal ingestion of diclofenac leading to renal failure in newborns

verfasst von: Varsha Phadke, Swati Bhardwaj, Bandya Sahoo, Sujata Kanhere

Erschienen in: Pediatric Nephrology | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

The use of non-steroidal anti-inflammatory drugs, such as indomethacin, ibuprofen, and nimesulide, during pregnancy has been reported to cause nephrotoxicity in the fetus. However, neonatal renal failure following antenatal exposure to diclofenac has not been reported in the literature. We report three cases of neonatal renal failure, including a pair of twins, following ingestion of diclofenac by the mother during pregnancy.

Case-Diagnosis/Treatment

Cases 1 and 2 involved a pair of twins born to a mother with oligohydramnios. The first twin had nonoliguric renal failure with incomplete recovery at day 17 of life. The second twin developed anuria and hyperkalemia on day 2 of life, for which peritoneal dialysis was initiated. After 20 days of peritoneal dialysis, the second twin remained oligo-anuric, developed peritonitis, and died. Case 3 involved a female infant born to a primigravida with severe oligohydramnios. The baby developed oliguria and renal failure after birth, which was managed conservatively. Creatinine normalized by day 15 of life and remained normal at 1 year of age. Ultrasonography in the first week of life showed that all three infants had normal-sized kidneys. Both mothers had been administered diclofenac during pregnancy.

Conclusions

In utero exposure to diclofenac may be associated with neonatal renal failure that may be transient or irreversible. We recommend that the use of diclofenac during pregnancy be avoided.
Literatur
1.
Zurück zum Zitat Cabrol D, Landesman R, Muller J, Uzan M, Sureau C, Saxena BB (1987) Treatment of polyhydramnios with prostaglandin synthetase inhibitor (indomethacin). Am J Obstet Gynecol 157:422–426PubMed Cabrol D, Landesman R, Muller J, Uzan M, Sureau C, Saxena BB (1987) Treatment of polyhydramnios with prostaglandin synthetase inhibitor (indomethacin). Am J Obstet Gynecol 157:422–426PubMed
2.
Zurück zum Zitat Moise KJ Jr, Hutha JC, Sharif DS, Ou CN, Kirshon B, Wasserstrum N, Cano L (1988) Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus N Engl J Med 319:327–331 Moise KJ Jr, Hutha JC, Sharif DS, Ou CN, Kirshon B, Wasserstrum N, Cano L (1988) Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus N Engl J Med 319:327–331
3.
Zurück zum Zitat Sawdy RJ, Groom KM, Bennett PR (2004) Experience of the use of nimesulide, a cyclo-oxygenase-2 selective prostaglandin synthesis inhibitor, in the prevention of preterm labour in 44 high-risk cases. J Obstet Gynaecol 24:226–229PubMedCrossRef Sawdy RJ, Groom KM, Bennett PR (2004) Experience of the use of nimesulide, a cyclo-oxygenase-2 selective prostaglandin synthesis inhibitor, in the prevention of preterm labour in 44 high-risk cases. J Obstet Gynaecol 24:226–229PubMedCrossRef
4.
Zurück zum Zitat Benini D, Fanos V, Cuzzolin L, Tato L (2004) In utero exposure to nonsteroidal anti-inflammatory drugs: neonatal renal failure. Pediatr Nephrol 19:232–234PubMedCrossRef Benini D, Fanos V, Cuzzolin L, Tato L (2004) In utero exposure to nonsteroidal anti-inflammatory drugs: neonatal renal failure. Pediatr Nephrol 19:232–234PubMedCrossRef
5.
Zurück zum Zitat Kömhoff M, Grone HJ, Klein T, Seyberth HW, Nüsing RM (1997) Localization of cyclooxygenase-1 and −2 in adult and fetal human kidney: implication for renal function. Am J Physiol 272:F460–468PubMed Kömhoff M, Grone HJ, Klein T, Seyberth HW, Nüsing RM (1997) Localization of cyclooxygenase-1 and −2 in adult and fetal human kidney: implication for renal function. Am J Physiol 272:F460–468PubMed
6.
Zurück zum Zitat Prévot A, Mosig D, Martini S, Guignard JP (2004) Nimesulide, a cyclooxygenase-2 preferential inhibitor, impairs renal function in the newborn rabbit. Pediatr Res 55:254–260PubMedCrossRef Prévot A, Mosig D, Martini S, Guignard JP (2004) Nimesulide, a cyclooxygenase-2 preferential inhibitor, impairs renal function in the newborn rabbit. Pediatr Res 55:254–260PubMedCrossRef
7.
Zurück zum Zitat Zenker M, Klinge J, Krüger C, Singer H, Scharf J (1998) Severe pulmonary hypertension in a neonate caused by premature closure of ductus arteriosus following maternal treatment with diclofenac: a case report. J Perinat Med 26:231–234PubMed Zenker M, Klinge J, Krüger C, Singer H, Scharf J (1998) Severe pulmonary hypertension in a neonate caused by premature closure of ductus arteriosus following maternal treatment with diclofenac: a case report. J Perinat Med 26:231–234PubMed
8.
Zurück zum Zitat Kaplan BS, Restaino I, Raval DS, Gottlieb RP, Bernstein J (1994) Renal failure in the neonate associated with in utero exposure to non-steroidal anti-inflammatory agents. Pediatr Nephrol 8:700–704PubMedCrossRef Kaplan BS, Restaino I, Raval DS, Gottlieb RP, Bernstein J (1994) Renal failure in the neonate associated with in utero exposure to non-steroidal anti-inflammatory agents. Pediatr Nephrol 8:700–704PubMedCrossRef
9.
Zurück zum Zitat Perruzzi L, Gianoglio B, Porcellini MG, Coppo R (1999) Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic. Lancet 354:1615CrossRef Perruzzi L, Gianoglio B, Porcellini MG, Coppo R (1999) Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic. Lancet 354:1615CrossRef
10.
Zurück zum Zitat Cataldi L, Leone R, Morelti U, De Mitri B, Fanos V, Ruggeri L, Sabatino G, Torcasio F, Zanardo V, Attardo G, Riccobene F, Martano C, Benini D, Cuzzolin L (2005) Potential risk factors for the development of acute renal failure in preterm newborn infants: a case control study. Arch Dis Child Fetal Neonatal Ed 90:F514–F519PubMedCrossRef Cataldi L, Leone R, Morelti U, De Mitri B, Fanos V, Ruggeri L, Sabatino G, Torcasio F, Zanardo V, Attardo G, Riccobene F, Martano C, Benini D, Cuzzolin L (2005) Potential risk factors for the development of acute renal failure in preterm newborn infants: a case control study. Arch Dis Child Fetal Neonatal Ed 90:F514–F519PubMedCrossRef
11.
Zurück zum Zitat Cuzzolin L, Fanos V, Pinna B, Di Marzio M, Perin M, Tramontozzi P, Tonetto P, Cataldi L (2006) Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions. Pediatr Nephrol 21:931–938PubMedCrossRef Cuzzolin L, Fanos V, Pinna B, Di Marzio M, Perin M, Tramontozzi P, Tonetto P, Cataldi L (2006) Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions. Pediatr Nephrol 21:931–938PubMedCrossRef
12.
Zurück zum Zitat Ali US, Khubchandani S, Andankar P, Parekhji S, Dubhalish V, Padhye B (2006) Renal tubular dysgenesis associated with in utero exposure to nimesulide. Pediatr Nephrol 21:274–276PubMedCrossRef Ali US, Khubchandani S, Andankar P, Parekhji S, Dubhalish V, Padhye B (2006) Renal tubular dysgenesis associated with in utero exposure to nimesulide. Pediatr Nephrol 21:274–276PubMedCrossRef
13.
Zurück zum Zitat Landau D, Shelef I, Polacheck H, Marks K, Holcberg G (1999) Perinatal vasoconstrictive renal insufficiency associated with maternal nimesulide use. Am J Perinatol 16:441–444PubMedCrossRef Landau D, Shelef I, Polacheck H, Marks K, Holcberg G (1999) Perinatal vasoconstrictive renal insufficiency associated with maternal nimesulide use. Am J Perinatol 16:441–444PubMedCrossRef
14.
Zurück zum Zitat Ali I, Ryan CA (2005) Transient renal failure in twins with maternal Cox 1 /Cox-2 use in pregnancy. Ir Med J 98:249–250PubMed Ali I, Ryan CA (2005) Transient renal failure in twins with maternal Cox 1 /Cox-2 use in pregnancy. Ir Med J 98:249–250PubMed
15.
Zurück zum Zitat Restaino I, Kaplan BS, Kaplan P, Rosenberg HK, Witzleben C, Roberts N (1991) Renal dysgenesis in a monozygotic twin: association with in utero exposure to indomethacin. Am J Med Genet 39:252–257PubMedCrossRef Restaino I, Kaplan BS, Kaplan P, Rosenberg HK, Witzleben C, Roberts N (1991) Renal dysgenesis in a monozygotic twin: association with in utero exposure to indomethacin. Am J Med Genet 39:252–257PubMedCrossRef
Metadaten
Titel
Maternal ingestion of diclofenac leading to renal failure in newborns
verfasst von
Varsha Phadke
Swati Bhardwaj
Bandya Sahoo
Sujata Kanhere
Publikationsdatum
01.06.2012
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 6/2012
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-012-2114-z

Weitere Artikel der Ausgabe 6/2012

Pediatric Nephrology 6/2012 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.